FDA Clears Wireless Maternal-Fetal Monitoring Platform
The wearable sensor system provides continuous, simultaneous monitoring of maternal and fetal vital signs to improve clinical evaluation.
The wearable sensor system provides continuous, simultaneous monitoring of maternal and fetal vital signs to improve clinical evaluation.
The cleared system introduces photon-counting CT designed to capture spectral data in a single scan and reduce protocol complexity.
The system brings surgical planning, real-time navigation, and robotic capabilities together in a single platform designed for spine procedures
The wearable sensor system provides continuous, simultaneous monitoring of maternal and fetal vital signs to improve clinical evaluation.
The clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.
Read MoreThe vendor-agnostic system enables remote scanning in a command center configuration and real-time remote expertise.
Read MoreThe software, powered by artificial intelligence and deep learning, assesses angiography-derived coronary physiology in patients with ischemic coronary artery disease.
Read MoreThe system is cleared to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal, and paranasal indications.
Read MoreNew FDA clearances authorize the use of an AI tool to detect lung nodules and help triage pneumothorax and pleural effusion on chest X-rays.
Read MoreThe Inogen Simeox 200 Airway Clearance Device aids bronchial drainage in patients with chronic respiratory conditions using high-frequency oscillatory vibrations and intermittent negative pressure.
Read More
Movano Health’s EvieMED Ring received FDA 510(k) clearance for its pulse oximeter, enabling expansion into clinical markets.